[2P-0611(2AW-09-1)] Identification of the synthetic lethal gene under the condition of PARG dysfunction and analysis of cell death mechanisms

〇Yuka Sasaki^1,2, Hiroaki Fujimori³, Miyuki Hozumi^3,4, Takae Onodera^1,2, Yasufumi Murakami⁴, Fumiaki Koizumi^5,1, Kengo Inoue⁶, Mitsuko Masutani^1,2 (1.Dept. Frontier Life Sci., Grad. Sch. Biomed. Sci., Nagasaki Univ., 2.Lab of Collaborative Research, Div. Cell Signaling, Natl. Cancer Ctr. Res. Inst., 3.Div. Chemother. and Clin. Res., Natl. Cancer Ctr. Res. Inst., 4.Tokyo Univ. Sci., Fac. Indus. Sci. Tech., 5.Div. Clin. Res. Support, Komagome Hosp., 6.Pharma Valley Center)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0612] Exploring repeat-fused genes expressed in cancer cells

〇Masaki Suimye Morioka¹, Hideya Kawaji^1,2 (1.IMS, RIKEN , 2.PMI, RIKEN)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0613] Tumor suppressor BHLHE41 is degraded by ubiquitin-proteasome pathway

〇Kentaro Minami¹, Ikuko Watanabe¹, Masatatsu Yamamoto¹, Kohichi Kawahara¹, Yoshinari Shinsato¹, Kazumasa Sekihara¹, Toshiyuki Nagata², Masami Sato², Tatsuhiko Furukawa¹ (1.Dept Mol Onc, Grad Sch, Med Dent Sci, Kagoshima Univ, 2.Dept Gen Thorac Surg, Grad Sch, Med Dent Sci, Kagoshima Univ)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0614] Episomal formation of Epstein-Barr virus induces oncogenic activation through aberrant enhancer activation

〇Atsushi Okabe¹, Keisuke Matsusaka¹, Masaki Fukuyo¹, Hiroe Namba¹, Sayaka Funata¹, Atsushi Kaneda¹ (1.Dept. of Mol. Oncology, Grad. Sch. Of Med., Chiba Univ.)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0615] Oncogenic activation of the ERK pathway alters miRNA expression profiles in exosomes

〇Shiho Hirose¹, Yuji Kubota¹, Mutsuhiro Takekawa¹ (1.Division of Cell Signaling and Molecular Medicine Institute of Medical Science The University of Tokyo )

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0616] Interaction between FGF2 and integrin enhances invasion ability of breast cancer cells.

〇Midori Goto¹, Seiji Mori², Yuki Yokoyama¹, Nariaki Matsuura³, Hirohumi Yamamoto¹ (1.Osaka Univ Grad Sch Med, Div Health Sci, Dept Path, 2.Morinomiya univ of Med Sci, Facul Health Sci, 3.Osaka Itn. Cancer Inst.)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0617] Predicting the three-dimensional structure of actinin-4mutants

〇Nami Miura¹, Kaoru Onidani¹, Kazufumi Honda^1,2 (1.Dept. of Biomar. Early Det. Cancer, Natl Cancer Ctr. Res. Inst., 2.CREST (AMED, CREST))

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0618] THG-1, a novel oncogene in tumor angiogenesis

〇Ling Zheng^1,2, Hiroyuki Suzuki¹, Mitsuyasu Kato¹ (1.Faculty of medicine, University of Tsukuba, 2.GIP-TRIAD)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0619] Spontaneous Cell Fusion between Cancer Cells and Mesenchymal Stem Cells in vivo

Youichi Tajima¹, 〇Futoshi Shibasaki¹ (1.Tokyo Metropolitan Institute of Medical Science)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0620] Expression profile and biochemical properties of dormant cancer cells prepared by cell fusion with mesenchymal stem cells

〇Youichi Tajima¹, Sadahiro Iwabuchi², Shinichi Hashimoto², Futoshi Shibazaki¹ (1.Dept of Mol.Med. Res., Tokyo Metr. Inst. Med. Sci., 2.Dept. integra. Med. for Longevity, Grad. Sch. of Med. Univ. of Kanazawa)

The 41st Annual Meeting of the Molecular Biology Society of Japan